Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells

BACKGROUND: Kallistatin is a serine proteinase inhibitor and heparin-binding protein. It is considered an endogenous angiogenic inhibitor. In addition, multiple studies demonstrated that kallistatin directly inhibits cancer cell growth. However, the molecular mechanisms underlying these effects rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guoquan, Wang, Xiao, Huang, Xiaoping, Yang, Huiyong, Pang, Suqiu, Xie, Xiaolan, Zeng, Shulan, Lin, Junsheng, Diao, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134261/
https://www.ncbi.nlm.nih.gov/pubmed/27980455
http://dx.doi.org/10.1186/s12935-016-0365-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134261/
https://www.ncbi.nlm.nih.gov/pubmed/27980455
http://dx.doi.org/10.1186/s12935-016-0365-7

Ejemplares similares